Deep Bio

About:

Deep Bio aims to utilize deep learning to realize unmet medical needs around the world, starting with the field of pathology.

Website: http://www.deepbio.co.kr

Twitter/X: DeepBio_Inc

Top Investors: Shinhan Venture Investment, Daesung Private Equity, Dt& Investment, Sejong Venture Partners, Hyundai Investment Partners

Description:

Deep Bio is a medical AI startup that aims to revolutionize cancer diagnosis. Deep Bio combines cutting-edge AI algorithms with digital pathology to empower pathologists and streamline existing workflows.

Total Funding Amount:

$5.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2015-10-08

Contact Email:

sales(AT)deepbio.co.kr

Founders:

Sun Woo Kim

Number of Employees:

11-50

Last Funding Date:

2020-03-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai